2020, Vol. 2, Issue 2, Part A

Introduction and Background: Respiratory impairment and increased susceptibility to infections are symptoms of interstitial lung disease (ILD), a category of chronic lung illnesses marked by inflammation and fibrosis. One of the most important diagnostic tools for determining which antibiotics to use in patients with ILD is the study of bronchoalveolar lavage (BAL) fluid. We hope to learn more about the clinical significance of the microbiological profile of BAL fluid in patients with ILD by doing this study.

Material and Methods: In a tertiary care hospital, 50 patients with ILD were the subjects of a prospective observational study. This study was conducted at the Department of Pulmonary Medicine, Sukh Sagar Medical College and Hospital, Chargawan, Jabalpur, Madhya Pradesh, India from November 2019 to June 2020. Purified BAL fluid was obtained using sterile fiberoptic bronchoscopy and analyzed microbiologically using techniques such as Gram staining, bacterial and fungal cultures, and polymerase chain reaction (PCR) for unusual infections. Isolates of bacteria were tested for their susceptibility to various antibiotics.

Results: In 42% of cases of ILD, microbiological infections were found. Klebsiella pneumoniae and Pseudomonas aeruginosa were the most often isolated bacteria at 24% and 18%, respectively, while Aspergillus spp. was the most prevalent fungal pathogen. Particularly against fluoroquinolones and cephalosporins, there was a high rate of antibiotic resistance. Patients whose BAL cultures were positive experienced a greater rate of mortality (30%) and a lengthier intensive care unit stay (13.8±3.0 days) in contrast to those whose cultures were negative (9.8±2.3 days, 18% mortality). Patients who were given a combination of immunosuppressant medications were more likely to have positive blood cultures.

Conclusion: The study emphasizes the heavy microbiological load in ILD patients, with Pseudomonas aeruginosa and multidrug-resistant Klebsiella pneumoniae being the most common infections. In order to enhance patient outcomes, the results highlight the necessity of focused antimicrobial interventions.